Theramex has announced that Evorel range is now available in the market.
The firm has earlier reported supply disruptions for the HRT patches.
Theramex said it has worked with multiple manufacturing partners to increase production capacity since its acquisition of the the Evorel portfolio in October 2019.
“We are now delighted to announce that the full Evorel range is back in stock. We would like to thank both patients and healthcare professionals for their patience as we stabilised the supply chain,” it said in an update.
Alliance Healthcare UK, the sole wholesaler to supply the Theramex product portfolio, including Evorel, to all pharmacies, hospitals, and dispensing doctors, is understood to have imposed a monthly quota for individual pharmacists.